文献速递技术与安全胸部腹部US

超声引导下微创尸检在COVID-19患者中的可行性与安全性

Feasibility and safety of ultrasound-guided minimally invasive autopsy in COVID-19 patients.
PubMed 文献 · Abdom Radiol (NY) · 2020-09-17

研究评估超声引导下微创尸检在COVID-19死亡患者中的可行性与安全性。60例中5例(8%)纳入,经13G同轴针行14G核心活检,按方案获取肝、肺、脾、心、肾等共112条组织芯;除2例肾萎缩未取到肾组织外,所有目标器官均成功取样,组织学质量优良,病理发现与既往COVID-19尸检报告一致。肺内SARS-CoV-2病毒载量最高,肝、脾次之且量少,心脏2/5(40%)载量低,肾脏0/3(0%)未检出病毒。

要点

  • 超声引导下经皮尸检核心活检可安全获取满足研究需要的组织,组织学质量优良。
  • 肺内SARS-CoV-2病毒载量最高,肝、脾次之且量少,心脏2/5(40%)载量低,肾脏0/3(0%)未检出。
  • 5例中2例因肾萎缩未获取肾组织,其余所有目标器官均成功取样。

核心结论

  • 超声引导下经皮尸检核心活检可安全提供足够的组织。
  • SARS-CoV-2病毒载量以肺最高,肝、脾次之,心肌内量少。

研究设计与样本

  • 研究类型为可行性研究,评估超声引导下微创尸检在COVID-19死亡患者中的可行性与安全性。
  • 2020年4月22日至2020年5月6日期间死亡的60例COVID-19患者中,基于研究人员的可用性考虑纳入,最终5例(5/60,8%)纳入研究。
  • 采用13G同轴针行14G核心活检,方案要求每例取肝20条、肺30条、脾12条、心20条、肾20条、乳腺4条、睾丸4条、骨骼肌2条、脂肪4条,共112条组织芯。
  • 样本质量通过组织芯数量、大小、组织学、免疫组化、针对COVID-19的原位杂交及PCR测定的SARS-CoV-2病毒载量评估。

诊断标准与关键数值

  • 所有到访家属均同意微创尸检。
  • 所有活检器官均在超声引导下成功定位并获取所需样本,仅2例因肾萎缩未获取肾组织。
  • 组织芯数量、大小和重量达到研究组的预期,组织组织学质量优良,病理发现与既往报道的COVID-19尸检发现一致。
  • 肺、肝、脾内检出最高SARS-CoV-2病毒载量,量为小到中等;心脏2/5(40%)检出低病毒载量;肾脏0/3(0%)未检出病毒。

临床应用与阅片要点

  • 超声引导下经皮尸检核心活检可用于获取COVID-19死亡患者多器官组织样本;原文报告肾萎缩病例可导致肾组织取样失败。
  • 原文未据此给出推荐。

局限性

  • 60例中仅5例(5/60,8%)纳入研究,样本量小。
  • 2例因肾萎缩未获取肾组织,肾脏病毒载量仅基于3例(0/3,0%)评估。
  • 心脏病毒载量仅在2/5(40%)检出低载量,其余例数原文未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine the feasibility and safety of ultrasound-guided minimally invasive autopsy in COVID-19 patients.

METHODS: 60 patients who expired between 04/22/2020-05/06/2020 due to COVID-19 were considered for inclusion in the study, based on availability of study staff. Minimally invasive ultrasound-guided autopsy was performed with 14G core biopsies through a 13G coaxial needle. The protocol required 20 cores of the liver, 30 of lung, 12 of spleen, 20 of heart, 20 of kidney, 4 of breast, 4 of testis, 2 of skeletal muscle, and 4 of fat with total of 112 cores per patient. Quality of the samples was evaluated by number, size, histology, immunohistochemistry, and in situ hybridization for COVID-19 and PCR-measured viral loads for SARS-CoV-2.

RESULTS: Five (5/60, 8%) patients were included. All approached families gave their consent for the minimally invasive autopsy. All organs for biopsy were successfully targeted with ultrasound guidance obtaining all required samples, apart from 2 patients where renal samples were not obtained due to atrophic kidneys. The number, size, and weight of the tissue cores met expectation of the research group and tissue histology quality was excellent. Pathology findings were concordant with previously reported autopsy findings for COVID-19. Highest SARS-CoV-2 viral load was detected in the lung, liver, and spleen that had small to moderate amount, and low viral load in was detected in the heart in 2/5 (40%). No virus was detected in the kidney (0/3, 0%).

CONCLUSIONS: Ultrasound-guided percutaneous post-mortem core biopsies can safely provide adequate tissue. Highest SARS-CoV-2 viral load was seen in the lung, followed by liver and spleen with small amount in the myocardium.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Brook OR, Piper KG, Mercado NB, et al. Feasibility and safety of ultrasound-guided minimally invasive autopsy in COVID-19 patients. Abdom Radiol (NY). 2020. PMID: 32939636. doi:10.1007/s00261-020-02753-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。